tiprankstipranks
Trending News
More News >

Guangzhou Baiyunshan Reports Decline in Q1 2025 Earnings

Story Highlights
Guangzhou Baiyunshan Reports Decline in Q1 2025 Earnings

Confident Investing Starts Here:

An announcement from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.

Guangzhou Baiyunshan Pharmaceutical Holdings Company reported a decrease in both income from operations and net profit for the first quarter of 2025 compared to the same period in 2024. The company experienced a 2.06% decline in income from operations and a 6.99% decrease in net profit attributable to shareholders. Additionally, the net cash flow from operating activities saw a significant drop of 24.19%. Despite these declines, the total equity attributable to shareholders increased by 5.05%, indicating a stronger financial position.

More about Guangzhou Baiyunshan Pharmaceutical Holdings Company

Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company with limited liability established in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.

YTD Price Performance: 2.18%

Average Trading Volume: 30,548

Technical Sentiment Signal: Strong Buy

Current Market Cap: $5.46B

See more insights into 0874 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App